Delivery Order SPE2DB22D3501-SPE2DB25FXL89
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Itovebi 3 mg tablets (28-count package). The contract, valued at $15,714.54, was awarded on August 14, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the vendor. The place of performance is...
- The Defense Logistics Agency awarded a $15,714.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Itovebi 3 mg tablets (28-count packaging) with a completion date of September 22, 2025. This firm fixed-price contract carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,714.54 to AmerisourceBergen Drug Corp for Itovebi 3 mg tablets (28-count units) under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of October 3, 2025. The contract represents a non-competitive delivery order with no set-aside designation, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,857.26 to AmerisourceBergen Drug Corp for ITOVEBI 3 MG tablets (28-count package). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,857.26 firm fixed-price contract is for the delivery of ITOVEBI 3 MG TABLET 28S, a pharmaceutical product, with a performance period ending on August 5, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,652.71 to AmerisourceBergen Drug Corp for 200 mg Ibtrozi capsules (30-count units) on November 7, 2025, with completion targeted for December 2, 2025. The contract carries firm fixed pricing and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,581.07 to AmerisourceBergen Drug Corp for the supply of Vanflyta 17.7 mg tablets (28-count units) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency for the supply of ATTRUBY 356 mg tablets (28 count). The contract, valued at $12,778.22, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. This is a non-set-aside competitive award, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXL89Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,714.54 to AmerisourceBergen Drug Corp for ITOVEBI 3 MG tablets (28-count supply) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems. The company maintains an extensive portfolio of federal contracts covering a wide spectrum of pharmaceutical products, from specialty medications to generic drugs, vaccines, and medical supplies. This particular delivery order for ITOVEBI represents a routine procurement of pharmaceutical inventory to support the military medical supply chain's ongoing operational requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 9/22/25 |